139
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma

, , , , , , , , & show all
Pages 6463-6475 | Published online: 08 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zehao Niu, Yan Li, Yujian Xu, Weiqian Jiang, Ran Tao, Youbai Chen & Yan Han. (2021) Silencing FYVE, RhoGEF, and PH domain containing 1 (FGD1) suppresses melanoma progression by inhibiting PI3K/AKT signaling pathway. Bioengineered 12:2, pages 12193-12205.
Read now

Articles from other publishers (13)

Nicole Natarelli, Aleena Boby, Shaliz Aflatooni, Jasmine Thuy Tran, Michael Joseph Diaz, Kamil Taneja & Mahtab Forouzandeh. (2023) Regulatory miRNAs and lncRNAs in Skin Cancer: A Narrative Review. Life 13:8, pages 1696.
Crossref
Joseph Toker, J. Bryan Iorgulescu, Alexander L. Ling, Genaro R. Villa, Josephina A.M.A. Gadet, Laxmi Parida, Gad Getz, Catherine J. Wu, David A. Reardon, E. Antonio Chiocca & Marco Mineo. (2023) Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors . Clinical Cancer Research 29:12, pages 2226-2238.
Crossref
Huiling Deng, Yuxuan Chen, Ran An & Jiecong Wang. (2023) Pyroptosis-related lncRNA prognostic signatures for cutaneous melanoma and tumor microenvironment status. Epigenomics 15:12, pages 657-675.
Crossref
Rebecca Distefano, Mirolyuba Ilieva, Jens Hedelund Madsen, Hideshi Ishii, Masanori Aikawa, Sarah Rennie & Shizuka Uchida. (2023) T2DB: A Web Database for Long Non-Coding RNA Genes in Type II Diabetes. Non-Coding RNA 9:3, pages 30.
Crossref
Xuezheng Xu, Yikun Ju, Xueheng Zhao, Pu Yang, Fang Zhu & Bairong Fang. (2023) SMG7-AS1 as a prognostic biomarker and predictor of immunotherapy responses for skin cutaneous melanoma. Genomics 115:3, pages 110614.
Crossref
Han She, Lei Tan, Yi Wang, Yuanlin Du, Yuanqun Zhou, Jun Zhang, Yunxia Du, Ningke Guo, Zhengbin Wu, Qinghui Li, Daiqin Bao, Qingxiang Mao, Yi Hu, Liangming Liu & Tao Li. (2023) Integrative single-cell RNA sequencing and metabolomics decipher the imbalanced lipid-metabolism in maladaptive immune responses during sepsis. Frontiers in Immunology 14.
Crossref
Chengren Li, Xu Liang & Yongguang Liu. (2022) lncRNA USP30-AS1 sponges miR-765 and modulates the progression of colon cancer. World Journal of Surgical Oncology 20:1.
Crossref
An-an Li, Fan Li, Min Lan, Yu Zhang, Dong Xie & Mei-ying Yan. (2022) A novel endoplasmic reticulum stress-related lncRNA prognostic risk model for cutaneous melanoma. Journal of Cancer Research and Clinical Oncology 148:12, pages 3227-3241.
Crossref
Yifan Tang, Huicong Feng, Lupeng Zhang, Chiwen Qu, Jinlong Li, Xiangyu Deng, Suye Zhong, Jun Yang, Xiyun Deng, Xiaomin Zeng, Yiren Wang & Xiaoning Peng. (2022) A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables. Scientific Reports 12:1.
Crossref
Yi Zhou, Qi Shu, Zailin Fu, Chen Wang, Jianrong Gu, Jianbo Li, Yifang Chen & Minghua Xie. (2022) A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma. Frontiers in Genetics 13.
Crossref
Hang Chen, Chongchang Zhou, Zeyang Hu, Menglu Sang, Saiqi Ni, Jiacheng Wu, Qiaoling Pan, Jingtao Tong, Kaitai Liu, Ni Li, Linwen Zhu & Guodong Xu. (2022) Construction of an algorithm based on oncosis‐related LncRNAs comprising the molecular subtypes and a risk assessment model in lung adenocarcinoma. Journal of Clinical Laboratory Analysis 36:6.
Crossref
Shuya Sun, Guanran Zhang & Litao Zhang. (2022) A Novel Ferroptosis-Related lncRNA Prognostic Model and Immune Infiltration Features in Skin Cutaneous Melanoma. Frontiers in Cell and Developmental Biology 9.
Crossref
Jingjing Ma, Qiong Shi, Sen Guo, Peng Xu, Xiuli Yi, Yuqi Yang, Weigang Zhang, Yu Liu, Lin Liu, Qiao Yue, Tao Zhao, Tianwen Gao, Weinan Guo & Chunying Li. (2022) Long Non-Coding RNA CD27-AS1-208 Facilitates Melanoma Progression by Activating STAT3 Pathway. Frontiers in Oncology 11.
Crossref